熱門資訊> 正文
Tectontic Therapy任命Daniel Lochner为首席财务官
2024-06-04 04:24
- Tectonic Therapeutic (NASDAQ:AVRO) on Monday announced the appointment of Daniel Lochner as Chief Financial Officer.
- Prior to joining Tectonic, Lochner served as Chief Business Officer and CFO of Viatris' Eye Care Division following Viatris’ acquisition of Oyster Point Pharma, where he had previously served as CFO and Chief Business Officer.
- Earlier in January, Tectonic entered into a definitive agreement to merge with AVROBIO.
- Source: Press Release
More on AVROBIO
- Seeking Alpha’s Quant Rating on AVROBIO
- Historical earnings data for AVROBIO
- Financial information for AVROBIO
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
